Catalog No.S1548 Synonyms: BMS-512148

Dapagliflozin Chemical Structure

Molecular Weight(MW): 408.87

Dapagliflozin is a potent and selective hSGLT2 inhibitor with EC50 of 1.1 nM, exhibiting 1200-fold selectivity over hSGLT1. Phase 4.

Size Price Stock Quantity  
In DMSO USD 280 In stock
USD 170 In stock
USD 320 In stock
USD 970 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

3 Customer Reviews

  • (B) Clonogenic survival of prostate cancer cells treated with Canagliflozin, Dapagliflozin or Salicylate and expressed relative to the vehicle controls.

    Mol Metab, 2016, 5(10):1048-56.. Dapagliflozin purchased from Selleck.

    Mol Cell Endocrinol, 2016, 420:37-45.. Dapagliflozin purchased from Selleck.

  • Mol Cell Biochem,2015, 400(1-2):57-68.. Dapagliflozin purchased from Selleck.

Purity & Quality Control

Choose Selective SGLT Inhibitors

Biological Activity

Description Dapagliflozin is a potent and selective hSGLT2 inhibitor with EC50 of 1.1 nM, exhibiting 1200-fold selectivity over hSGLT1. Phase 4.
Features More potent stimulator of glucosuria than other SGLT2 inhibitors.
hSGLT2 [1]
1.1 nM(EC50)
In vitro

Dapagliflozin is not sensitive to hSGLT1 with a 1200-fold IC50. [1] Dapagliflozin is 32-fold more potent than phlorizin against hSGLT2 but 4-fold less than phlorizin against hSGLT1. Dapagliflozin is highly selective versus GLUT transporters and displays 8–9% inhibition in protein-free buffer at 20 μM and virtually no inhibition in the presence of 4% bovine serum albumin. [2] Dapagliflozin has good permeability across Caco-2 cell membranes and is a substrate for P-glycoprotein (P-gp) but not a significant P-gp inhibitor. Dapagliflozin is stable in rat, dog, monkey, and human serum at 10 μM. Dapagliflozin shows no inhibitory responses or induction to human P450 enzymes. The in vitro metabolic pathways Dapagliflozin are glucuronidation, hydroxylation, and O-deethylation. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
CHO cells M3:2fmZ2dmO2aX;uJIF{e2G7 M2O3dlIhcA>? NUW4bJlWUW6qaXLpeIlwdiCxZjDoeY1idiCVR1zUNkBmgHC{ZYPz[YQhcW5iQ1jPJINmdGy|IHHzd4V{e2WmIHHzJHsyPEOfYXzwbIEudWW2aInsMWQu\2y3Y3;wfZJidm:|aXTlJJVxfGGtZTDh[pRmeiB{IHjyd{BjgSCuaYH1bYQhe2OrboTpcIxifGmxbjDjc5VvfGmwZzygTWM2OD1yLkCwNFQ6KM7:TR?= NUjEfWNOOjB2M{S5NFk>
CHOK1 cells MYXGeY5kfGmxbjDhd5NigQ>? M{TrPFMhcA>? MXPJcohq[mm2aX;uJI9nKGi3bXHuJHNIVFR{IHX4dJJme3OnZDDpckBEUE:NMTDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKFtzNFPdMWFOTyC3cIThb4Uh[W[2ZYKgN{BpenNiYomgcYlkem:kZYThJJNkcW62aXzsZZRqd25iY3;1cpRqdmdiYX7hcJl{cXNuIFnDOVA:OC5yMEGg{txO NIjlTWQzPDh2Mk[xPC=>
HEK293.ETN cells M1z5T2Z2dmO2aX;uJIF{e2G7 NGPkRpYyNjViaB?= M4\kVmlvcGmkaYTpc44hd2ZiaIXtZY4hW0eOVEKgeJJidnOoZXP0[YQhcW5iSFXLNlk{NkWWTjDj[YxteyCjc4Pld5Nm\CCjczDBUWchfXC2YXvlJIFnfGW{IEGuOUBpenNiYomgd4NqdnSrbHzheIlwdiClb4XueIlv\yxiSVO1NF0xNjByNkeg{txO NV\kR5I5OTl6OU[zO|Q>
COS-7 cells MlzjSpVv[3Srb36gZZN{[Xl? NVX0WoJ1OiCq MkD6TY5pcWKrdHnvckBw\iCqdX3hckBUT0yWMTD0doFve2[nY4Tl[EBqdiCFT2OtO{Bk\WyuczDhd5Nme3OnZDDhd{BCVUdidYD0ZYtmKGGodHXyJFIhcHK|IHL5JJNkcW62aXzsZZRqd25iY3;1cpRqdmduIFnDOVA:OC56OTFOwG0> NYDuNFFQOTl6OU[zO|Q>

... Click to View More Cell Line Experimental Data

In vivo Dapagliflozin reduces blood glucose levels by 55% after 0.1 mg/kg oral dose in hyperglycemic streptozotocin (STZ) rats, which is in part to the metabolic stability conferred by the C-glucoside linkage. Dapagliflozin displays a favorable absorption, distribution, metabolism, and excretion (ADME) profile and is orally bioavailable. [1] Dapagliflozin (1 mg/kg) causes significant dose-dependent glucosuria and increase in urine volume in normal rats over 24 hours post-dose. Dapagliflozin induces increase in urine glucose and urine volume excretion at 6 hours post-dose in Zucker diabetic fatty (ZDF) rats. Dapagliflozin lowers fasting and fed glucose levels in ZDF rats even by 2 weeks of treatment, without any marker of renal or liver toxicity. [2] Dapagliflozin significantly reduces the development of hyperglycaemia, with lowered blood glucose. Dapagliflozin could improve the insulin sensitivity, reduce β-cell mass and the development of impaired pancreatic function. [4]


Animal Research:[1]
+ Expand
  • Animal Models: Normal Sprague Dawley rats or streptozotocin induced male Sprague Dawley rats
  • Formulation: 5% mpyrol, 20% PEG400, and 20 mM sodium diphosphate
  • Dosages: 0.01-10 mg/kg (1 mL/kg) followed by a 50% glucose solution (2 g/kg)
  • Administration: Dosed orally
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 82 mg/mL (200.55 mM)
Ethanol 17 mg/mL (41.57 mM)
Water slightly soluble or insoluble
In vivo Add solvents individually and in order:
30% PEG400+0.5% Tween80+5% propylene glycol
30 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 408.87


CAS No. 461432-26-8
Storage powder
in solvent
Synonyms BMS-512148

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03036150 Recruiting Chronic Kidney Disease AstraZeneca February 2017 Phase 3
NCT03036124 Not yet recruiting Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) AstraZeneca February 2017 Phase 3
NCT02987738 Not yet recruiting Type1diabetes Kinderkrankenhaus auf der Bult|AstraZeneca|Alcedis GmbH February 2017 Phase 1
NCT03030235 Not yet recruiting Chronic Heart Failure With Preserved Systolic Function Saint Lukes Health System February 2017 Phase 4
NCT02919345 Not yet recruiting Diabetes Mellitus, Type 2|Coronary Artery Disease|Carotid Artery Diseases University of Campinas, Brazil|AstraZeneca January 2017 Phase 4
NCT02981966 Not yet recruiting Diabetes Mellitus, Type 2 The University of Texas Health Science Center at San Antonio|AstraZeneca January 2017 Phase 4

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

SGLT Signaling Pathway Map

Related SGLT Products

Tags: buy Dapagliflozin | Dapagliflozin supplier | purchase Dapagliflozin | Dapagliflozin cost | Dapagliflozin manufacturer | order Dapagliflozin | Dapagliflozin distributor
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID